SCA Pharma Responds to COVID-19: A Blog Series
‘Meeting the Challenge of Abrupt Product Mix Changes and Social Distancing During Covid-19’
COVID-19 has transformed the delivery of health care in ways many of us could not have imagined. But as the crisis continues and evolves, it’s important to learn from early lessons COVID-19 has taught us.
In a series of blogs and videos, senior leaders at SCA Pharma address the pandemic’s impact on quality, operations, product demand, and overall customer service during these challenging times.
In this video, Michelle Wood, Vice President of Sales and Marketing, shares how SCA Pharma’s sales team is adapting to market and workplace changes to ensure that hospitals get the vital medicines they need during the pandemic. Click here to watch the video, the last in our four-part series.
You can download our updated list of medications to treat COVID-19 here.
To see all installments of this blog series, click here.
SCA Pharma is an FDA 503B outsourcing facility providing the highest quality sterile admixtures and pre-filled syringes. SCA Pharma specializes in preparing sterile pharmaceuticals customized for hospital pharmacies and healthcare facilities nationwide.
Headquartered in Little Rock, Arkansas, SCA Pharma has two state-of-the-art production facilities in Arkansas and Connecticut. For more information, contact marketing@scapharma.com.
